This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 600+ CE and professional development courses.

Goals and Learning Outcomes

Numerous classes of drugs are used to treat bipolar disorder (BD). Several guidelines cover what type of drug to use, depending on the symptoms and patient presentation. The healthcare team needs to have in-depth knowledge of medications used to reduce acute symptoms of BD and improve quality of life.

The goal of this course is to assist the healthcare team in keeping up to date with medications used in the management of BD.


After taking this course, you should be able to:

  • Discuss the etiology, pathophysiology, goals of treatment, and challenges in the management of bipolar disorder.
  • Determine the appropriate medication indicated for the acute phases of mania, depression, mixed feature, and maintenance of bipolar disorder.
  • Describe the pharmacology, contraindications, and adverse effects of medications used to manage bipolar disorder.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/26

Course Originally Released On: 07/01/23

Course Authors

4.4 Average

Course Reviews

5807 reviews

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.